SCHEMBL9372896

SCHEMBL9372896

CCN1C(=O)c2ccccc2N(C)c2nc(Cl)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ MPI P34949 1/20 0.47
▸ CACNA1B Q00975 1/20 0.47
▸ APBA1 Q02410 1/20 0.47
▸ MAPK7 Q13164 4/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ BRD4 O60885 4/20 0.43
▸ DCLK1 O15075 3/20 0.43
▸ LRRK2 Q5S007 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ DRD2 P14416 2/20 0.43
▸ HTR6 P50406 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ DRD1 P21728 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9369781 0.89 TNK2 (0.42) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL16979656 0.85 BRD4 (0.52) ALDH1A1HPGDCACNA1BAPBA1MAPK7
SCHEMBL8546607 0.84 L3MBTL1 (0.42) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL20094162 0.82 MAPK7 (0.51) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL9370046 0.80 BRD4 (0.48) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL19496544 0.78 MAPK7 (0.52) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL21311761 0.77 MAPT (0.67) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL22473980 0.74 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2HPGDCASP1MPI
SCHEMBL8889357 0.73 CYP3A4 (0.42) L3MBTL1BRD4
SCHEMBL8791127 0.71 BRD4 (0.48) ALDH1A1SMN1; SMN2HPGDCASP1MPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0393530-B1 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMA (US) 1994-12-28 — — EP claimed
EP-0393530-A1 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1990-10-24 — — EP claimed
EP-0393530-B1 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMA (US) 1994-12-28 — — EP disclosed
US-5087625-A Pyridodiazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1992-02-11 — — US disclosed
EP-0393530-A1 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1990-10-24 — — EP disclosed
Send feedback